Get startedLog in
    Picture of Newbury Pharmaceuticals AB logo

    NEWBRY — Newbury Pharmaceuticals AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    Consumer DefensivesHighly SpeculativeMicro CapMomentum Trap
    All News

    Brief: Newbury Pharmaceuticals Starts DCP Filing For Teduglutide On Day-1 Following Expiry Of Data Exclusivity

    Picture of Newbury Pharmaceuticals AB logoNewbury Pharmaceuticals AB
    13/09/2024 12:53
    Sept 13 (Reuters) - Newbury Pharmaceuticals AB
 NEWBRY.ST :
    * INITIATED A DCP FILING FOR TEDUGLUTIDE ON DAY-1 FOLLOWING
EXPIRY
OF DATA EXCLUSIVITY

Source text for Eikon:  ID:nMFN5r7M28 
Further company coverage:  NEWBRY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Newbury Pharmaceuticals AB

    See all news